AZD4547
Cat.No:IA2440 Solarbio
CAS:1035270-39-3
Molecular Formula:C26H33N5O3
Molecular Weight:463.57
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to yellow Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Angiogenesis >
AZD4547CAS:1035270-39-3
Molecular Formula:C26H33N5O3
Molecular Weight:463.57
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to yellow Solid
Qty:
Size:
CAS | 1035270-39-3 |
Name | AZD4547 |
Molecular Formula | C26H33N5O3 |
Molecular Weight | 463.57 |
Solubility | Soluble in DMSO |
Purity | ≥98% |
Appearance | White to yellow Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
MDL | MFCD22580423 |
SMILES | C[C@@H]1CN(C[C@@H](N1)C)C2=CC=C(C=C2)C(=O)NC3=NNC(=C3)CCC4=CC(=CC(=C4)OC)OC |
Target Point | FGFR |
Passage | Angiogenesis; Protein Tyrosine Kinase/RTK |
Background | AZD4547 is a novel selective FGFR inhibitor. |
Biological Activity | AZD4547 是一种有效的 FGFR 家族抑制剂,作用于 FGFR1,FGFR2,FGFR3 和 FGFR4,IC50 分别为 0.2 nM,2.5 nM,1.8 nM 和 165 nM。[1] |
IC50 | FGFR1:0.2nM;FGFR2:2.5nM;FGFR3:1.8nM;FGFR4:165nM[1] |
Data Literature Source | [1]. Gavine PR,et al. AZD4547: an orally bioavailable,potent,and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family. Cancer Res,2012,72(8),2045-2056 |
Unit | Bottle |
Specification | 5mg 10mM*1mL in DMSO 10mg 50mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.